Altered levels of focal adhesion and extracellular matrix‐receptor interacting proteins were identified in Hailey‐Hailey disease by quantitative iTRAQ proteome analysis. Issue 3 (3rd December 2018)

• Record Type: Journal Article
• Authors: Zhang, Dingwei; Huo, Jia; Li, Ruilian; Zhang, Yanfei; Wang, Zhenghui; Li, Xiaoli
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 3(2019)
• Page Start: 3801
• Page End: 3812
• Publication Date: 2018-12-03
• Subjects: Gene Ontology -- Hailey‐Hailey disease -- iTRAQ -- KEGG -- proteome; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.27662
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Benign chronic familial pemphigus or Hailey‐Hailey disease (HHD, OMIM 169600) is a rare, autosomal dominant blistering skin disorder characterized by suprabasal cell separation (acantholysis) of the epidermis. To date, the proteomic changes in skin lesions from HHD patients has not been reported yet. In this study, a sample of skin lesions from HHD patients was collected for isobaric tags for relative and absolute quantitation to analyze proteome changes compared with unaffected individuals. The 134 differentially expressed proteins were assigned to at least one Gene Ontology term, and 123 annotated proteins with significant matches were assigned to 187 known metabolic or signaling pathways listed in the Kyoto Encyclopedia of Genes and Genomes. Most of the altered proteins in skin lesions of HHD patients were enriched in pathways involved in the PI3K‐Akt signaling, focal adhesion, extracellular matrix (ECM)‐receptor interaction, and protein digestion and absorption, such as collagen family members, microfibril‐associated glycoprotein 4 and plakophilin. The changes of proteins related to cell adhesion, ECM‐receptor interaction, and protein folding and glycosylation suggested that strategy targeted to alter cell junction and extracellular microenvironment might provide a potential treatment for HHD. Abstract : The proteome of skin lesions from HHD patients was assembled and used for iTRAQ to analyze changes in skin lesions compared with unaffected individuals